Barclays raised the firm’s price target on Ambev (ABEV) to $3 from $2.50 and keeps an Equal Weight rating on the shares. The company enters 2026 positioned for profitability-led earnings and cash flow growth, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEV:
- Ambev Earnings Call: Margins Rise Amid Volume Strain
- Ambev Files Routine February 2026 Form 6-K as Foreign Private Issuer
- Ambev Board Approves 2025 Financials and Sets April IOC Payment
- Ambev Sets April Payment Date for First 2026 Interest-on-Capital Tranche
- Ambev Posts 2025 Earnings Growth Despite Volume Drop and Sets April Payout Date